Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists

por Seow, Vernon, Lim, Junxian, Cotterell, Adam J., Yau, Mei-Kwan, Xu, Weijun, Lohman, Rink-Jan, Kok, W. Mei, Stoermer, Martin J., Sweet, Matthew J., Reid, Robert C., Suen, Jacky Y., Fairlie, David P.
Publicado 2016